Growth Drivers

Attractive Valuation Relative to Peers: AUNA trades at a low EV/EBITDA (6.0x) and EV/Sales (1.1x) compared to regional healthcare peers, suggesting the market is discounting its growth potential and providing a favorable entry point for long-term investors if fundamentals are sustained.

Defensive Cash Flow Profile: The company demonstrates a robust free cash flow yield (0.36), indicating strong cash generation relative to enterprise value, which supports reinvestment and debt service over the next decade.

Efficient Capital Allocation: AUNA maintains a low capex-to-revenue ratio (2.4%) and a negative cash conversion cycle, reflecting disciplined capital spending and efficient working capital management, which can underpin margin stability and growth.

AUNA’s combination of attractive valuation, strong cash flow generation, and efficient capital allocation positions it well for long-term growth relative to peers, provided it can sustain operational performance and manage leverage.

Growth Limitations

Elevated Leverage: Net debt to EBITDA stands at 4.3x, above sector averages, which may constrain future investment capacity and increase refinancing risk if cash flows weaken.

Limited Historical Growth Visibility: Absence of reported 5-year revenue, EPS, and FCF CAGRs limits confidence in the company’s ability to deliver sustained top- and bottom-line growth over a 10-year horizon.

Modest Profitability Metrics: Return on invested capital (5.4%) is below global healthcare leaders, suggesting limited value creation and potential margin pressure if competitive intensity rises.

AUNA’s growth outlook is tempered by high leverage, lack of long-term growth track record, and only moderate profitability, which could cap upside if not addressed.

Scalable Growth Initiatives

Potential for Regional Expansion: AUNA’s efficient capital structure and cash flow profile provide a foundation for expansion into underpenetrated Latin American healthcare markets, which could drive outsized growth if executed prudently.

Operational Efficiency Programs: The company’s negative cash conversion cycle and disciplined capex suggest ongoing focus on operational improvements, which can be scaled to enhance margins and returns.

Balance Sheet Optimization: If AUNA can deleverage through organic cash flow or asset optimization, it could unlock additional investment capacity and reduce risk, supporting scalable growth.

AUNA has credible levers for scalable growth, particularly through regional expansion and operational efficiency, but successful execution and balance sheet management are critical.

Structural Risk Factors

Macroeconomic and Currency Exposure: Operating in Latin America exposes AUNA to currency volatility and macroeconomic shocks, which could impact cash flows and valuation over the next decade.

Healthcare Regulatory Uncertainty: Changes in healthcare policy or reimbursement frameworks in core markets could disrupt revenue streams and increase compliance costs.

Refinancing and Interest Rate Risk: Elevated leverage and weaker interest coverage (1.6x) increase sensitivity to rising rates or tightening credit conditions, which could pressure liquidity.

AUNA faces manageable but material structural risks from macroeconomic, regulatory, and financial exposures, which require ongoing mitigation to preserve long-term value.

Overall Score

AUNA offers a strong 10-year growth profile relative to valuation, underpinned by cash flow strength and operational efficiency. However, elevated leverage, limited historical growth data, and external risks temper the outlook. Execution on expansion and deleveraging will be key to realizing its long-term potential.